(Ohio State University Medical Center) A study led by Ohio State University Comprehensive Cancer Center and National Cancer Institute researchers suggests that a molecule called miR-21 is important in the development of lung cancer in never-smokers and in smokers.
Lung tumors from never-smokers with mutations in a gene called EGFR had particularly high levels of the molecule.
The findings may lead to improve targeted therapy for lung cancer, including tumors resistant to targeted drugs such as gefitinib.
Post new comment